North America DVT Preventive Pump Market

The North America DVT preventive pump market is expected to grow from US$ 159.01 million in 2022 to US$ 209.64 million by 2028; it is estimated to record a CAGR of 4.7% from 2022 to 2028.

Rising Cases of Cardiac Disorders and Stroke Favor North America DVT Preventive Pump Market Growth

Cardiovascular diseases (CVDs) are one of the leading causes of death in North America. People from low- and middle-income countries in North America suffer from noncommunicable diseases such as CVDs, as they have minimal access to effective and equitable health services. Moreover, patients with cardiac diseases are at a significantly higher risk of heart disease and stroke than the general population, which can lead to the development of deep vein thrombosis (DVT). The incidence of heart failure and atrial fibrillation is twice among patients with coronary artery disease, which, in turn, contributes to the prevalence of DVT. Stroke remains an immense concern for public health authorities, regardless of advancements made for understanding several factors associated with the condition, including epidemiology, quality of life, and pathophysiology. Per the American Heart Association, stroke is the fifth-highest cause of death in the US, resulting in 1 in 6 deaths in 2020. In 2019, the US registered 460,000 stroke cases (two-thirds were ischemic), out of which 190,000 cases resulted in deaths and 3.83 million cases led to stroke-disability-adjusted life years. Therefore, the rising cases of cardiac disorders and stroke are boosting the prevalence of DVT in North America, thereby driving the growth of the North America DVT preventive pump market.

North America DVT Preventive Pump Market Overview

The North America DVT preventive pump market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to technological advancements related to the treatment of DVT. The US was the first country that approved an interventional device for the treatment of pulmonary embolism. It is a safe, repeatable, and reliable treatment that dissolves thrombus quickly, with low lytic, and less blood loss and trauma. It uses ultrasonic care technology, which is a minimally invasive method that is completed within 15 minutes.

North America DVT preventive pump Market Revenue and Forecast to 2028 (US$ Million)

North America DVT Preventive Pump Strategic Insights

Strategic insights for the North America DVT Preventive Pump provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America DVT Preventive Pump Report Scope

North America DVT Preventive Pump Regional Insights

The geographic scope of the North America DVT Preventive Pump refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America DVT preventive pump Market Segmentation

The North America DVT preventive pump market is segmented on the basis of service type, end user, and country.

Based on type, the North America DVT preventive pump market is bifurcated into lower extremity and upper extremity. The lower extremity testing segment held a larger market share in 2022.

The North America DVT preventive pump market, by end user, is segmented into hospitals and clinics, surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

In terms of country, the North America DVT preventive pump market is segmented into the US, Canada, and Mexico. The US dominated the market in this region in 2022.

Devo Medical Products Inc., Breg Inc., Bio Compression Systems Inc., Cardinal Health Inc., Arjo AB, Mego Afek Ltd., DJO LLC, Currie Medical Specialities Inc., Zimmer Biomet Holdings Inc., and ThermoTek Inc. are among the leading companies operating in the North America DVT preventive pump market.